BIO-key Files 8-K for 'Other Event' on Jan 8, 2024
Ticker: BKYI · Form: 8-K · Filed: Jan 11, 2024 · CIK: 1019034
| Field | Detail |
|---|---|
| Company | Bio Key International INC (BKYI) |
| Form Type | 8-K |
| Filed Date | Jan 11, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: other-events, routine-filing
TL;DR
**BIO-key filed a routine 8-K for an 'Other Event' on Jan 8, 2024, no major news.**
AI Summary
BIO-key International, Inc. filed an 8-K on January 11, 2024, reporting an 'Other Event' that occurred on January 8, 2024. This filing is a routine disclosure indicating no major financial or operational changes, but rather a standard update to their public record. For investors, this means there's no immediate new information impacting the stock, suggesting a period of stability or lack of significant news from the company.
Why It Matters
This filing is a standard disclosure and does not contain specific new information that would immediately impact BIO-key International, Inc.'s stock price or valuation. It signals business as usual, without any major positive or negative developments.
Risk Assessment
Risk Level: low — This 8-K filing is for an 'Other Event' and does not disclose any specific financial or operational changes, thus posing a low risk.
Analyst Insight
A smart investor would note this routine filing, understand it contains no new material information, and continue to monitor for more substantive disclosures or operational updates from BIO-key International, Inc.
Key Players & Entities
- BIO-key International, Inc. (company) — the registrant filing the 8-K
- January 8, 2024 (date) — the date of the earliest event reported in the 8-K
- January 11, 2024 (date) — the filing date of the 8-K
- Delaware (company) — state of incorporation for BIO-key International, Inc.
- 1-13463 (dollar_amount) — Commission File Number for BIO-key International, Inc.
FAQ
What is the purpose of this specific 8-K filing by BIO-key International, Inc.?
This 8-K filing is categorized under 'Item Information: Other Events', indicating a disclosure of an event that occurred on January 8, 2024, which the company deems important to report but doesn't fit into other specific 8-K categories.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 8, 2024, as stated under 'Date of Report (Date of earliest event reported): January 8, 2024'.
What is the full legal name of the company filing this 8-K?
The exact name of the registrant as specified in its charter is BIO-key International, Inc.
Where is BIO-key International, Inc. incorporated?
BIO-key International, Inc. is incorporated in Delaware, as indicated by 'Delaware (State or other jurisdiction of incorporation)'.
What is the trading symbol and exchange for BIO-key International, Inc.'s Common Stock?
The Common Stock of BIO-key International, Inc. trades under the symbol BKYI on the Nasdaq Capital Market, as listed under 'Securities registered pursuant to Section 12(b) of the Act'.
Filing Stats: 531 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-01-11 11:54:32
Key Financial Figures
- $1.00 — ment to maintain a minimum bid price of $1.00 per share, as set forth in Nasdaq Listi
Filing Documents
- bkyi20240110_8k.htm (8-K) — 21KB
- 0001437749-24-001159.txt ( ) — 152KB
- bkyi-20240108.xsd (EX-101.SCH) — 3KB
- bkyi-20240108_def.xml (EX-101.DEF) — 12KB
- bkyi-20240108_lab.xml (EX-101.LAB) — 15KB
- bkyi-20240108_pre.xml (EX-101.PRE) — 12KB
- bkyi20240110_8k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events.   As previously reported on January 12, 2023 and July 12, 2023, BIO-key International, Inc. (the " Company ") received notices from The Nasdaq Stock Market, LLC (" Nasdaq ") indicating that the Company was not in compliance with the continued listing requirement to maintain a minimum bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the " Bid Price Rule ").   As of January 5, 2024, the closing bid price of the Company's common stock was greater than $1.00 per share for 10 consecutive business days. By letter dated January 8, 2024, Nasdaq notified the Company that based on the forgoing, Nasdaq determined that the Company is now in compliance with the Bid Price Rule and that the matter has been closed. Based on the forgoing, the Company is currently in compliance with the Bid Price Rule.  
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     BIO-KEY INTERNATIONAL, INC.   Date: January 11, 2024         By: /s/ Cecilia C. Welch       Cecilia C. Welch       Chief Financial Officer